Natália Fernandes Frota
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Natália Fernandes Frota has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Marcos Roberto Lourenzoni
Protein Engineering and Health Solutions Group, Oswaldo Cruz Foundation, Fiocruz Ceará, Eusébio, Ceará, CEP 61.773-270, Brazil; Postgraduate Program in Biotechnology of Natural Resources, Federal University of Ceará, Campus do Pici, 825, Fortaleza, Ceará, CEP 60.440-970, Brazil
3 shared publications - Tatiana de Arruda Campos Brasil de Souza
Laboratory for Structural and Computational Proteomics, Carlos Chagas Institute, Fundação Oswaldo Cruz Paraná (Fiocruz-PR), Curitiba 80320-290, Brazil
2 shared publications - Alison de Sousa Rebouças
Research Group on Protein Engineering and Health Solutions (GEPeSS), Fundação Oswaldo Cruz Ceará (Fiocruz-CE), São José, Precabura, 61760000, Eusébio, Ceara, Brazil; Federal University of Ceara (UFC), Campus do Pici (Bloco 873), 60440-970, Fortaleza, Ceara Brazil
1 shared publication Ana Virginia Frota Guimarães
Programa de Pós Graduação em Biotecnologia de Recursos Naturais, Departamento de Engenharia de Pesca, Universidade Federal do Ceará, Campus do Pici, 825, zip-code: 60356-000, Fortaleza, CE, Brazil; Fundação Oswaldo Cruz - Ceará, Fiocruz - CE, Protein Engineering and Health Solutions Group - GEPeSS, zip-code: 60175-047, Fortaleza, CE, Brazil
1 shared publicationCarlos Alessandro Fuzo
Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil
1 shared publication- Fabio Cesar Gozzo
Department of Chemistry, Unicamp, Sao Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 5 August 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (15) , 8708
Molecular Dynamics of CYFIP2 Protein and Its R87C Variant Related to Early Infantile Epileptic Encephalopathy
The CYFIP2 protein (cytoplasmic FMR1-interacting protein 2) is part of the WAVE regulatory complex (WRC). CYFIP2 was recently correlated to neurological disorders by the association of the R87C variant with early infantile epileptic encephalopathy (EIEE) patients. In this set of syndromes, the epileptic spasms and seizures since early childhood lead to impaired neurological development in children. Inside the WRC, the variant residue is at the CYFIP2 and WAVE1 protein interface. Thus, the hypothesis is that the R87C modification weakens this interaction, allowing the WRC complex’s constant activation. This work aimed to investigate the impacts of the mutation on the structure of the WRC complex through molecular dynamics simulation. For that, we constructed WRC models containing WAVE1-NCKAP1 proteins complexed with WT or R87C CYFIP2. Our simulations showed a flexibilization of the loop comprising residues 80–110 due to the loss of contacts between internal residues in the R87C CYFIP2 as well as the key role of residues R/C87, E624, and E689 in structural modification. These data could explain the mechanism by which the mutation impairs the stability and proper regulation of the WRC.
- 5 August 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (15) , 8708
Open AccessMolecular Dynamics of CYFIP2 Protein and Its R87C Variant Related to Early Infantile Epileptic Encephalopathy
The CYFIP2 protein (cytoplasmic FMR1-interacting protein 2) is part of the WAVE regulatory complex (WRC). CYFIP2 was recently correlated to neurological disorders by the association of the R87C variant with early infantile epileptic encephalopathy (EIEE) patients. In this set of syndromes, the epileptic spasms and seizures since early childhood lead to impaired neurological development in children. Inside the WRC, the variant residue is at the CYFIP2 and WAVE1 protein interface. Thus, the hypothesis is that the R87C modification weakens this interaction, allowing the WRC complex’s constant activation. This work aimed to investigate the impacts of the mutation on the structure of the WRC complex through molecular dynamics simulation. For that, we constructed WRC models containing WAVE1-NCKAP1 proteins complexed with WT or R87C CYFIP2. Our simulations showed a flexibilization of the loop comprising residues 80–110 due to the loss of contacts between internal residues in the R87C CYFIP2 as well as the key role of residues R/C87, E624, and E689 in structural modification. These data could explain the mechanism by which the mutation impairs the stability and proper regulation of the WRC.
- 1 December 2021
- Published by Elsevier in Journal of Molecular Graphics and Modelling
- Vol. 109, 108007
Molecular dynamics simulations of human L-asparaginase1: Insights into structural determinants of enzymatic activity
- 1 December 2021
- Published by Elsevier in Journal of Molecular Graphics and Modelling
- Vol. 109, 108007
Molecular dynamics simulations of human L-asparaginase1: Insights into structural determinants of enzymatic activity
- 1 September 2021
- Published by Elsevier in Journal of Molecular Graphics and Modelling
- Vol. 107, 107949
Alemtuzumab scFv fragments and CD52 interaction study through molecular dynamics simulation and binding free energy
- 1 September 2021
- Published by Elsevier in Journal of Molecular Graphics and Modelling
- Vol. 107, 107949
Alemtuzumab scFv fragments and CD52 interaction study through molecular dynamics simulation and binding free energy
- 1 July 2020
- Published by Elsevier in Journal of Proteomics
- Vol. 224, 103818
The role of the quaternary structure in the activation of human L-asparaginase
- 1 July 2020
- Published by Elsevier in Journal of Proteomics
- Vol. 224, 103818
The role of the quaternary structure in the activation of human L-asparaginase